Deal snapshot: Infectious Disease Connect Combines with US Merck's ILAsM Health Solutions.

MANews-(C)2009-2020

US-based drugmaker Merck's (NYSE: MRK) ILAsM Health Solutions has combined with Infectious Disease Connect Inc., a University of Pittsburgh Medical Center-backed company offering telemedicine-enabled solutions to hospitals for treatment of infectious diseases, to support infectious disease management, clinical decision-support and precision antibiotic therapy, Merck said.

As part of this agreement, UPMC...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT